NCT07401823Phase 2Terminated

Open-Label Extension Study to Pioneer Study 6058-SCD-101

Study sponsor: Fulcrum Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-06-04Actual
Enrollment · participants1Actual
Source updated2026-10-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 50 participants (planned). After: 1 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 4 Feb 2030. After: 4 Jun 2026.

Recruitment status changed

Before: Enrolling by invitation. After: Terminated.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Enrolling by invitation.

Check registry source